PIKFYVE and cancer: Nanomolar concentrations of PIKFYVE inhibitors in groups A, B and C rapidly and reversibly inhibit proliferation of PIKFYVE-dependent cancer cells and pluripotent stem cells concomitant with inhibition of lysosome fission, endosomal trafficking, endosome maturation, and cathepsin maturation.